Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo
- 1 September 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (9), 2063-2069
- https://doi.org/10.1161/01.atv.0000235694.69719.e2
Abstract
Objective— Because late vein graft failure is caused by intimal hyperplasia (IH) and accelerated atherosclerosis, and these processes are thought to be inflammation driven, influx of monocytes is one of the first phenomena seen in IH, we would like to provide direct evidence for a role of the MCP-1 pathway in the development of vein graft disease. Methods and Results— MCP-1 expression is demonstrated in various stages of vein graft disease in a murine model in which venous interpositions are placed in the carotid arteries of hypercholesterolemic ApoE3Leiden mice and in cultured human saphenous vein (HSV) segments in which IH occurs. The functional involvement of MCP-1 in vein graft remodeling is demonstrated by blocking the MCP-1 receptor CCR-2 using 7ND-MCP-1. 7ND-MCP1 gene transfer resulted in 51% reduction in IH in the mouse model, when compared with controls. In HSV cultures neointima formation was inhibited by 53%. In addition, we demonstrate a direct inhibitory effect of 7ND-MCP-1 on the proliferation of smooth muscle cell (SMC) in HSV cultures and in SMC cell cultures. Conclusion— These data, for the first time, prove that MCP-1 has a pivotal role in vein graft thickening due to intimal hyperplasia and accelerated atherosclerosis.Keywords
This publication has 19 references indexed in Scilit:
- Antimonocyte Chemoattractant Protein-1 Gene Therapy Attenuates Graft VasculopathyArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularizationJournal of the American College of Cardiology, 2004
- Diseased vein grafts express elevated inflammatory cytokine levels compared with atherosclerotic coronary arteriesThe Annals of Thoracic Surgery, 2004
- Accelerated Atherosclerosis and Calcification in Vein GraftsCirculation Research, 2002
- Protective Function of Transcription Factor TR3 Orphan Receptor in AtherogenesisCirculation, 2002
- Essential Role of Monocyte Chemoattractant Protein-1 in Development of Restenotic Changes (Neointimal Hyperplasia and Constrictive Remodeling) After Balloon Angioplasty in Hypercholesterolemic RabbitsCirculation, 2002
- Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-κB and Activator Protein-1Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damageGene Therapy, 2001
- Mouse Model of Venous Bypass Graft ArteriosclerosisThe American Journal of Pathology, 1998
- The Relation of Risk Factors to the Development of Atherosclerosis in Saphenous-Vein Bypass Grafts and the Progression of Disease in the Native CirculationThe New England Journal of Medicine, 1984